Skip to main content

Advertisement

SpringerLink
Log in

Dimethylesculetin ameliorates maternal glucose intolerance and fetal overgrowth in high-fat diet-fed pregnant mice via constitutive androstane receptor

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The constitutive androstane receptor (CAR) has been reported to decrease insulin resistance along with obesity. 6,7-dimethylesculetin (DE) is an active component of Yin Zhi Huang which is a traditional Asian medicine used to treat neonatal jaundice via CAR. In this study, we examined whether DE could affect the expression of gluconeogenic and lipogenic genes via human CAR pathway using human HepG2 cells in vitro. We also studied whether DE treatment during pregnancy could prevent maternal hypertension, glucose intolerance and hyperlipidemia, and fetal overgrowth in high-fat diet (HFD)-induced obese pregnant mice. Dimethylesculetin suppressed the mRNA expression of gluconeogenic genes, phosphoenolpyruvate carboxykinase and glucose-6-phosphatase, and lipogenic genes, sterol regulatory element-binding protein 1 and stearoyl-CoA desaturase 1, and enhanced CAR-mediated transcription. Blocking the CAR-mediated pathway abolished the effect of DE in vitro. DE treatment during pregnancy could prevent maternal hypertension, glucose intolerance and hyperlipidemia, and fetal overgrowth in HFD-induced obese pregnant mice in vivo. Our data indicate that DE might be a potential therapeutic agent for obese pregnant patients with insulin resistance through CAR to prevent the perinatal outcomes such as preeclampsia, gestational diabetes, and macrosomia. Further analysis of possible complications and side effects using animal models is required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Duckitt K, Harrington D (2005) Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330:565

    Article  PubMed  PubMed Central  Google Scholar 

  2. Seely EW, Solomon CG (2003) Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 88:2393–2398

    Article  CAS  PubMed  Google Scholar 

  3. Catalano PM, Ehrenberg HM (2006) The short- and long-term implications of maternal obesity on the mother and her offspring. BJOG 113:1126–1133

    Article  CAS  PubMed  Google Scholar 

  4. Cnattingius S, Bergstrom R, Lipworth L, Kramer MS (1998) Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med 338:147–152

    Article  CAS  PubMed  Google Scholar 

  5. American Diabetes Association (2000) Type 2 diabetes in children and adolescents. Diabetes Care 23:381–389

    Article  Google Scholar 

  6. Boney CM, Verma A, Tucker R, Vohr BS (2005) Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes. Pediatrics 115:e290–296

    Article  PubMed  Google Scholar 

  7. Innes KE, Wimsatt JH, McDuffie R (2001) Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol 97:905–910

    CAS  PubMed  Google Scholar 

  8. Wolf M, Sandler L, Munoz K (2002) First trimester insulin resistance and subsequent preeclampsia: a prospective study. J Clin Endocrinol Metab 87:1563–1568

    Article  CAS  PubMed  Google Scholar 

  9. Masuyama H, Segawa T, Sumida Y, Masumoto A, Inoue S, Akahori Y, Hiramatsu Y (2010) Different profiles of circulating angiogenic factors and adipocytokines between early- and late-onset preeclampsia. BJOG 117:314–320

    Article  CAS  PubMed  Google Scholar 

  10. Suwaki N, Masuyama H, Nakatsukasa H, Masumoto A, Sumida Y, Takamoto N, Hiramatsu Y (2006) Hypo-adiponectinemia and circulating angiogenic factors in overweight patients complicated with preeclampsia. Am J Obstet Gynecol 195:1687–1692

    Article  CAS  PubMed  Google Scholar 

  11. di Masi A, De Marinis E, Ascenzi P, Marino M (2009) Nuclear receptors CAR and PXR: molecular, functional, and biomedical aspects. Mol Asp Med 30:297–343

    Article  Google Scholar 

  12. Baes M, Gulick T, Choi HS, Martinoli MG, Simha D, Moore DD (1994) A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol 14:1544–1552

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Choi HS, Chung M, Tzameli I, Simha D, Lee YK, Seol W, Moore DD (1997) Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J Biol Chem 272:23565–23571

    Article  CAS  PubMed  Google Scholar 

  14. Roth A, Looser R, Kaufmann M, Meyer UA (2008) Sterol regulatory element binding protein 1 interacts with pregnane X receptor and constitutive androstane receptor and represses their target genes. Pharmacogenet Genomics 18:325–337

    Article  CAS  PubMed  Google Scholar 

  15. Ueda A, Hamadeh HK, Webb HK, Yamamoto Y, Sueyoshi T, Afshari CA, Lehmann JM, Negishi M (2002) Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol 61:1–6

    Article  CAS  PubMed  Google Scholar 

  16. Dong B, Saha PK, Huang W, Chen W, Abu-Elheiga LA, Wakil SJ, Stevens RD, Ilkayeva O, Newgard CB, Chan L, Moore DD (2009) Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci USA 106:18831–18836

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Gao J, He J, Zhai Y, Wada T, Xie W (2009) The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem 284:25974–25982

    Google Scholar 

  18. Masuyama H, Hiramatsu Y (2012) Treatment with a constitutive androstane receptor ligand ameliorates the signs of preeclampsia in high-fat diet induced obese pregnant mice. Mol Cell Endocrinol 348:120–127

    Article  CAS  PubMed  Google Scholar 

  19. Chen ZL, Guan WH (1985) Approach to the effect and indication of Yin Zhi Huang to treat neonatal jaundice. J Clin Pediatr 3:302–303

    Google Scholar 

  20. Yang SH, Lu CF (1984) Effects of decoction of Artemisia, Rheum, Gardenia, Coptidis and Rhizoma on neonatal jaundice in Chinese newborn infants. J Chin Child Med 25:144–148

    Google Scholar 

  21. Huang W, Zhang J, Moore DD (2004) A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J Clin Invest 113:137–143

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Li L, Chen T, Stanton JD, Sueyoshi T, Negishi M, Wang H (2008) The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol 74:443–453

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 278:17277–17283

    Article  CAS  PubMed  Google Scholar 

  24. Masuyama H, Hiramatsu Y (2011) Potential role of estradiol and progesterone in insulin resistance through constitutive androstane receptor. J Mol Endocrinol 47:229–239

    Article  CAS  PubMed  Google Scholar 

  25. Masuyama H, Nakatsukasa H, Hiramatsu Y (2010) Effect of oncostatin M on uridine diphosphate-50-glucuronosyltransferase 1A1 through crosstalk with constitutive androstane receptor. Mol Endocrinol 24:745–753

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Sueyoshi T, Kawamoto T, Zelko I, Honkakoski P, Negishi M (1999) The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 274:6043–6046

    Article  CAS  PubMed  Google Scholar 

  27. Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, Turner RC (1986) Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in men. Diabetologia 28:401–411

    Article  Google Scholar 

  28. Swales K, Negishi M (2004) CAR, driving into the future. Mol Endocrinol 18:1589–1598

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by research Grants (No. 25462558) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata, Kita-ku, Okayama, 700-8558, Japan

    Hisashi Masuyama, Takashi Mitsui, Jota Maki, Kazumasa Tani, Keiichiro Nakamura & Yuji Hiramatsu

Authors
  1. Hisashi Masuyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Mitsui
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jota Maki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazumasa Tani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keiichiro Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuji Hiramatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hisashi Masuyama.

Ethics declarations

Conflict of interest

No competing interests are declared any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Masuyama, H., Mitsui, T., Maki, J. et al. Dimethylesculetin ameliorates maternal glucose intolerance and fetal overgrowth in high-fat diet-fed pregnant mice via constitutive androstane receptor. Mol Cell Biochem 419, 185–192 (2016). https://doi.org/10.1007/s11010-016-2772-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-016-2772-4

Keywords

Search

Navigation